Comparison Of Levodopa Dose Frequency And Parkinson’s Kinetigraph Metrics For Screening Advanced Parkinson’s Disease
Objective: 1. Evaluate how well levodopa dose frequency and Parkinson's Kinetigraph (PKG) metrics correspond with the 5-2-1 criteria for identifying Advanced Parkinson Disease (APD)2. Determine…Risk factors for dysautonomic fluctuations in Mexican PwP
Objective: To identify risk factors for non-motor dysautonomic fluctuations in people living with Parkinson’s disease (PwP). Background: Advanced Parkinson’s disease (PD) is characterized by motor…Are we overlooking wearing off? Evaluating the role of the WOQ-9 questionnaire in routine Parkinson’s care
Objective: 1. Evaluate clinicians’ ability to recognise wearing-off compared with the Wearing Off Questionnaire-9 (WOQ-9)2. Assess patient awareness of wearing-off symptoms Background: Wearing off is…Comparative efficacy and safety of Safinamide versus Opicapone in Japanese patients with Parkinson’s Disease and wearing-off: A matching-adjusted indirect comparison
Objective: To compare efficacy and safety outcomes with safinamide and opicapone as adjuncts to levodopa in Parkinson’s disease (PD) patients with wearing-off using an anchored…Assessing Concordance Between Clinical judgment And 5-2-1 Criteria In Advanced Parkinsons Disease
Objective: 1. Assess how accurately clinicians diagnose Advanced Parkinson’s Disease (APD) in a routine clinical setting2. Evaluate concordance between 5-2-1 criteria and clinician judgement, including…Dynamics of Motor Fluctuations and Medication Challenges in Parkinson’s Disease
Objective: To investigate the dynamics of tremor, bradykinesia, and finger dexterity during the OFF-to-ON transition using objective measures. Additionally, assesses medication administration challenges through a…Early Use of a Conversational Assistant to Interpret Wearable and Patient-Reported Data in Parkinson Disease
Objective: To evaluate early real-world use of a bounded conversational assistant that helps people with Parkinson disease interpret wearable and patient-reported data and identify when…Single centre experience with subcutaneous foslevodopa/foscarbidopa for GBA Parkinson’s disease
Objective: To describe the clinical outcomes of two patients with GBA Parkinson’s disease (GBA-PD) and severe motor fluctuations treated with subcutaneous foslevodopa/foscarbidopa (fld/fcd) infusion. Background:…Objective detection of morning bradykinesia in Parkinson’s Disease using a wearable inertial sensor
Objective: To evaluate whether a wearable inertial sensor (WIS) can detect and characterize morning bradykinesia (MB) in patients with Parkinson’s disease (PD). Background: Morning bradykinesia…Opicapone as adjunct to levodopa in Chinese patients with Parkinson’s disease and wearing-off: a randomized, double-blind, placebo-controlled phase 3 trial
Objective: To evaluate the efficacy and safety of once-daily opicapone as adjunct to levodopa in Chinese patients with Parkinson’s disease (PD) and wearing-off, and to…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 29
- Next Page »